Urodynamix Technologies is a Canadian medical device company that develops and commercializes non-invasive medical devices based on proprietary applications of near-infrared spectroscopy (NIRS) for the diagnosis of urological diseases and conditions, including:

• Lower urinary tract symptoms

• Overactive bladder

• Prostate cancer

• Benign prostatic hyperplasia

• Erectile dysfunction

Urodynamix is a publicly traded company and is listed on the TSX Venture Exchange under the symbol URO.  The Company is certified to ISO 13485:2003 Medical Device Quality Management Systems standards.

Under the leadership of President and CEO Barry Allen, Urodynamix strives to develop innovative medical devices to improve the quality of patient health worldwide.